MYC and cancer: Overall, studies have shown that there is a multi-faceted interplay between mammalian sirtuin proteins and the MYC and HIF transcription factor families (Table 1 and Fig. 3), potentially rendering some of the sirtuins attractive therapeutic targets to reverse metabolic reprogramming in cancer cells.